OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Read original article ↗
Related Articles
ChatGPT hits 60,000 advertisers as OpenAI cuts prices
OpenAI is expanding its ChatGPT advertising business by cutting ad prices, adding campaign tools and recruiting advertis
Microsoft says AI agents are like insider threats as ‘frontier models can’t be trusted’
Microsoft wants enterprises to closely watch the agents employees use with systems not controlled by AI labs like OpenAI
OpenAI Engineer Accused of Spying on Executives Ordered to Remain in Custody
A judge ordered Abdulrahman Alfozan to remain in custody, likening the Saudi government’s offer to secure the former Ope